06/10/2022
A new study reveals the importance of Medicaid coverage, methadone, and delivery of health and social services to improve access and retention of pregnant and non-pregnant women in Los Angeles, California. CHAS - Center for Health Administration Studies, I-Lead Institute, ,
Read our full study here:
A new @opioidtx study reveals the importance of Medicaid coverage, methadone, and delivery of health and social services to improve access and retention of pregnant and non-pregnant women in Los Angeles, California. - REHD Corp
Dr. Erick Guerrero and the iSATed research team.
12/22/2021
Women in Los Angeles may not be getting their needs met in standard opioid use disorder programs. We found poorer treatment outcomes in women who were treated with methadone as well as in women who identified as Latina. CHAS - Center for Health Administration Studies, I-Lead Institute,
Read our full study here: https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00389-4
12/15/2021
Women who seek opioid use disorder treatment spend longer on waiting lists but remain in treatment longer than men. CHAS - Center for Health Administration Studies, I-Lead Institute Guerrero,
Read our full study here:https://www.isated.com/wp-content/uploads/2021/05/JSAT-Gender-Disparities-in-Opioid-Access-and-Retention-Pub.pdf
12/06/2021
Tarzana Treatment Centers College invites you to join their Leaders on Leaders Podcast livestream, happening today. Learn about Opioid Use Disorder treatment and Medications for Addiction Treatment (MAT). The panel will include I-Lead Institute and Research to End Healthcare Disparities Corp, Research Director, Erick Guerrero, Ph.D. ,
Medications for Addiction Treatment Livestream
Expert leaders discussing the Medications for Addiction Treatment and the future of Opioid Use Disorder Treatment
